Catalyst Wire Dossier Catalyst Wire Dossier

Diclofenac DDEA 2.32% gel

diclofenac diethylamine 2.32% gel · Novartis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Diclofenac DDEA 2.32% gel, covering 2015-06-03 to 2015-06-03. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Diclofenac DDEA 2.32 % in Patient Suffering From Knee Osteoarthritis (OA) [Phase 3]

See pricing